410 related articles for article (PubMed ID: 25748073)
1. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.
Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP
J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073
[TBL] [Abstract][Full Text] [Related]
2. Industry sponsorship and selection of comparators in randomized clinical trials.
Lathyris DN; Patsopoulos NA; Salanti G; Ioannidis JP
Eur J Clin Invest; 2010 Feb; 40(2):172-82. PubMed ID: 20050879
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.
Bero L; Oostvogel F; Bacchetti P; Lee K
PLoS Med; 2007 Jun; 4(6):e184. PubMed ID: 17550302
[TBL] [Abstract][Full Text] [Related]
4. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
[TBL] [Abstract][Full Text] [Related]
5. Spine device clinical trials: design and sponsorship.
Cher DJ; Capobianco RA
Spine J; 2015 May; 15(5):1133-40. PubMed ID: 25637470
[TBL] [Abstract][Full Text] [Related]
6. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.
Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C
Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044
[TBL] [Abstract][Full Text] [Related]
7. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.
Sinyor M; Schaffer A; Smart KA; Levitt AJ; Lanctôt KL; Grysman NH
J Clin Psychiatry; 2012 Feb; 73(2):e277-87. PubMed ID: 22401489
[TBL] [Abstract][Full Text] [Related]
8. Sponsors' participation in conduct and reporting of industry trials: a descriptive study.
Lundh A; Krogsbøll LT; Gøtzsche PC
Trials; 2012 Aug; 13():146. PubMed ID: 22920226
[TBL] [Abstract][Full Text] [Related]
9. The uncertainty principle and industry-sponsored research.
Djulbegovic B; Lacevic M; Cantor A; Fields KK; Bennett CL; Adams JR; Kuderer NM; Lyman GH
Lancet; 2000 Aug; 356(9230):635-8. PubMed ID: 10968436
[TBL] [Abstract][Full Text] [Related]
10. A Review of Industry Funding in Randomized Controlled Trials Published in the Neurosurgical Literature-The Elephant in the Room.
Khan NR; Saad H; Oravec CS; Rossi N; Nguyen V; Venable GT; Lillard JC; Patel P; Taylor DR; Vaughn BN; Kondziolka D; Barker FG; Michael LM; Klimo P
Neurosurgery; 2018 Nov; 83(5):890-897. PubMed ID: 29462484
[TBL] [Abstract][Full Text] [Related]
11. Outcomes, Interventions and Funding in Randomised Research Published in High-Impact Journals.
Grey P; Grey A; Bolland MJ
Trials; 2018 Oct; 19(1):592. PubMed ID: 30373636
[TBL] [Abstract][Full Text] [Related]
12. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I
Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121
[TBL] [Abstract][Full Text] [Related]
13. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
[TBL] [Abstract][Full Text] [Related]
14. Influence of study sponsorship on head and neck cancer randomized trial results.
Sun GH; Houlton JJ; MacEachern MP; Bradford CR; Hayward RA
Head Neck; 2013 Oct; 35(10):1515-20. PubMed ID: 22987508
[TBL] [Abstract][Full Text] [Related]
15. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study.
Falk Delgado A; Falk Delgado A
Trials; 2017 Jul; 18(1):354. PubMed ID: 28747226
[TBL] [Abstract][Full Text] [Related]
16. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
[TBL] [Abstract][Full Text] [Related]
17. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
Als-Nielsen B; Chen W; Gluud C; Kjaergard LL
JAMA; 2003 Aug; 290(7):921-8. PubMed ID: 12928469
[TBL] [Abstract][Full Text] [Related]
18. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ
CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094
[TBL] [Abstract][Full Text] [Related]
19. The association between funding by commercial interests and study outcome in randomized controlled drug trials.
Yaphe J; Edman R; Knishkowy B; Herman J
Fam Pract; 2001 Dec; 18(6):565-8. PubMed ID: 11739337
[TBL] [Abstract][Full Text] [Related]
20. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I
Trials; 2011 Feb; 12():58. PubMed ID: 21356072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
